Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 1.000 | |
| 5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.510 | |
| 3b8q | 900 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.496 | |
| 3eta | 351 | Insulin receptor | 2.7.10.1 | 0.492 | |
| 2rl5 | 2RL | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.490 | |
| 3tub | FPU | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.489 | |
| 4tyj | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.489 | |
| 4uxq | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.480 | |
| 2oiq | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.479 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.479 | |
| 1yhs | STU | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.470 | |
| 3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.467 | |
| 4qrc | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.464 | |
| 3nax | MP7 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.462 | |
| 4h1j | 0YH | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.461 | |
| 3ce3 | 1FN | Hepatocyte growth factor receptor | 2.7.10.1 | 0.456 | |
| 4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 0.455 | |
| 4elb | 34R | Dihydrofolate reductase | / | 0.454 | |
| 3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.453 | |
| 1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.452 | |
| 4o2z | 046 | Mitogen-activated protein kinase | / | 0.451 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.451 | |
| 2y98 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.450 | |
| 4kao | KAO | Focal adhesion kinase 1 | 2.7.10.2 | 0.450 | |
| 1xdd | AAY | Integrin alpha-L | / | 0.448 | |
| 4k0y | 1OA | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.447 | |
| 2yac | 937 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.446 | |
| 4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.446 | |
| 4v01 | 0LI | Fibroblast growth factor receptor 1 (Fms-related tyrosine kinase 2, Pfeiffer syndrome), isoform CRA_b | / | 0.446 | |
| 4eev | L1X | Hepatocyte growth factor receptor | 2.7.10.1 | 0.445 | |
| 4i6h | 1C8 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.445 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.443 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.442 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.442 | |
| 3cth | 319 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.441 | |
| 3aba | FLI | Cytochrome P450 | / | 0.440 |